Auranofin sensitizes breast cancer cells to paclitaxel chemotherapy by disturbing the cellular redox system.

Natarajan, Deepika; Prasad, N Rajendra; Sudharsan, M; Bharathiraja, Pradhapsingh; Lakra, Deepa Swati

Natarajan, Deepika; Prasad, N Rajendra; Sudharsan, M; Bharathiraja, Pradhapsingh; Lakra, Deepa Swati.

Afiliación

Natarajan D; Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar, Tamil Nadu, India.
Prasad NR; Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar, Tamil Nadu, India.
Sudharsan M; Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar, Tamil Nadu, India.
Bharathiraja P; Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar, Tamil Nadu, India.
Lakra DS; Department of Biochemistry and Biotechnology, Annamalai University, Annamalainagar, Tamil Nadu, India.

Cell Biochem Funct ; 41(8): 1305-1318, 2023 Dec.

Article en En | MEDLINE | ID: mdl-37792847

Asunto(s)

Neoplasias de la Mama; Paclitaxel; Humanos; Femenino; Paclitaxel/farmacología; Paclitaxel/uso terapéutico; Auranofina/farmacología; Auranofina/uso terapéutico; Neoplasias de la Mama/tratamiento farmacológico; Neoplasias de la Mama/metabolismo; Oxidación-Reducción; Línea Celular Tumoral; Células MCF-7; Apoptosis

Palabras clave

antioxidants; auranofin; breast cancer; chemosensitization; redox status

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Paclitaxel Límite: Female / Humans Idioma: En Revista: Cell Biochem Funct Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google